Sven Lee’s addition to GBI Biomanufacturing’s board marks a strategic move to further enhance the company’s leadership in the biologics CDMO industry. With over three decades of experience, GBI has solidified itself as a trusted manufacturing partner for complex biologics. Sven’s expertise in commercialization, licensing, and strategic growth will be instrumental in expanding GBI’s global reach and maintaining its reputation for excellence in biopharmaceutical manufacturing.